Literature DB >> 22646022

Adipokines and the cardiovascular system: mechanisms mediating health and disease.

Josette M Northcott1, Azadeh Yeganeh, Carla G Taylor, Peter Zahradka, Jeffrey T Wigle.   

Abstract

This review focuses on the role of adipokines in the maintenance of a healthy cardiovascular system, and the mechanisms by which these factors mediate the development of cardiovascular disease in obesity. Adipocytes are the major cell type comprising the adipose tissue. These cells secrete numerous factors, termed adipokines, into the blood, including adiponectin, leptin, resistin, chemerin, omentin, vaspin, and visfatin. Adipose tissue is a highly vascularised endocrine organ, and different adipose depots have distinct adipokine secretion profiles, which are altered with obesity. The ability of many adipokines to stimulate angiogenesis is crucial for adipose tissue expansion; however, excessive blood vessel growth is deleterious. As well, some adipokines induce inflammation, which promotes cardiovascular disease progression. We discuss how these 7 aforementioned adipokines act upon the various cardiovascular cell types (endothelial progenitor cells, endothelial cells, vascular smooth muscle cells, pericytes, cardiomyocytes, and cardiac fibroblasts), the direct effects of these actions, and their overall impact on the cardiovascular system. These were chosen, as these adipokines are secreted predominantly from adipocytes and have known effects on cardiovascular cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22646022     DOI: 10.1139/y2012-053

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  27 in total

Review 1.  Obesity: the 'huge' problem in cardiovascular diseases.

Authors:  M Javed Ashraf; Paramdeep Baweja
Journal:  Mo Med       Date:  2013 Nov-Dec

Review 2.  What can blood biomarkers tell us about cardiovascular risk in obstructive sleep apnea?

Authors:  Ivan Guerra de Araújo Freitas; Pedro Felipe Carvalhedo de Bruin; Lia Bittencourt; Veralice Meireles Sales de Bruin; Sérgio Tufik
Journal:  Sleep Breath       Date:  2015-02-26       Impact factor: 2.816

3.  Assessment of Serum VASPIN Levels among Type 2 Diabetes Mellitus Patients with or without Acute Coronary Syndrome.

Authors:  Aswathy Jaya Sathyaseelan; Prashant Shankarrao Adole; Mukta Wyawahare; Rama Prakasha Saya
Journal:  J Clin Diagn Res       Date:  2016-12-01

4.  Adipose tissue and serum CCDC80 in obesity and its association with related metabolic disease.

Authors:  O Osorio-Conles; M Guitart; J M Moreno-Navarrete; X Escoté; X Duran; J M Fernandez-Real; A M Gomez-Foix; S Fernández-Veledo; J Vendrell
Journal:  Mol Med       Date:  2017-08-23       Impact factor: 6.354

5.  Identification of functional leptin receptors expressed in ventricular mitochondria.

Authors:  Eduardo Martinez-Abundis; Venkatesh Rajapurohitam; Arieh Gertler; Morris Karmazyn
Journal:  Mol Cell Biochem       Date:  2015-06-30       Impact factor: 3.396

Review 6.  Adipokines: novel players in resistant hypertension.

Authors:  Ana Paula de Faria; Rodrigo Modolo; Vanessa Fontana; Heitor Moreno
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-09-04       Impact factor: 3.738

Review 7.  Adipose tissue dysfunction in nascent metabolic syndrome.

Authors:  Andrew A Bremer; Ishwarlal Jialal
Journal:  J Obes       Date:  2013-04-04

Review 8.  Does the sympathetic nervous system contribute to the pathophysiology of metabolic syndrome?

Authors:  Marina C Dos Santos Moreira; Izabella S de Jesus Pinto; Aline A Mourão; James O Fajemiroye; Eduardo Colombari; Ângela A da Silva Reis; André H Freiria-Oliveira; Marcos L Ferreira-Neto; Gustavo R Pedrino
Journal:  Front Physiol       Date:  2015-08-25       Impact factor: 4.566

Review 9.  The New Kid on the Block: The Mechanisms of Action of Hyperleptinemia in Coronary Artery Disease and Atherosclerosis.

Authors:  Vernicia Hernandez; Kavaljeet Kaur; Mohamed W ElSharief; Sari W Al Hajaj; Ahmed M Ebrahim; Mirash Razack; David Dragas
Journal:  Cureus       Date:  2021-06-20

10.  Improvement in coronary heart disease risk factors during an intermittent fasting/calorie restriction regimen: Relationship to adipokine modulations.

Authors:  Cynthia M Kroeger; Monica C Klempel; Surabhi Bhutani; John F Trepanowski; Christine C Tangney; Krista A Varady
Journal:  Nutr Metab (Lond)       Date:  2012-10-31       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.